Breaking: Sacklers reach new $7.4 billion settlement over opioid crisis

The tentative agreement in a federal bankruptcy court adds $1.4 billion to a previous deal that had been scuttled last year by the U.S. Supreme Court.

Log In    Subscribe BREAKING NEWS   Sacklers reach new $7.4 billion settlement over opioid crisis By Ed Silverman Toby Talbot/AP Purdue Pharma and members of the Sackler family that own the company have agreed to a $7.4 billion settlement in principle with 15 states to resolve thousands of lawsuits filed over the role they allegedly played in fomenting the long-running opioid crisis in the U.S.   The tentative agreement in a federal bankruptcy court adds $1.4 billion to a previous deal that had been scuttled last year by the U.S. Supreme Court over the insistence of some Sackler family members who sought immunity from future lawsuits. READ MORE Sign up for Pharmalot From the lab to the medicine chest, these are the must-read drug industry updates of the day. Learn more. In Case You Missed It 1   FDA approves Purdue Pharma's controversial new overdose-reversal medication By Lev Facher 2   An NYC nonprofit has reversed 1,700 overdoses since 2021. Under Trump, it faces an uncertain future By Lev Facher 3   Biden administration moves to expand, preserve access to addiction treatments as term expires By Lev Facher 4   Purdue's Richard Sackler proposed plan to play down OxyContin risks, and wanted drug maker feared 'like a tiger,' files show By Casey Ross Don't miss out on another STAT Investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us